Zantac
In October 2019, a class-action lawsuit was filed against Sanofi for allegedly misleadingly marketing the over-the-counter heartburn medication Zantac as safe when, according to plaintiffs, the medicine contains dangerously high levels of the carcinogen N-nitrosodimethylamine (NDMA). (Rodriguez et al v. Sanofi U.S. LLC et al, Case No. 19-cv-9527, S. D. NY.)
Class-Action Tracker
The Latest
Stellantis pulls Jeep, Ram and Dodge tariff-response ads after built-in-USA scrutiny
E.J. Schultz, Ad Age
Stellantis Steers Away from Deceptive Made in USA Claims
MADISON, CONN. April 9, 2025 — Dutch automaker Stellantis has paused its new “American Born” campaign after getting called out by consumer advocacy organization truthinadvertising.org (TINA.org). Released in the wake…
Jeep, Dodge and Ram Pump the Brakes on Built in USA Claims Following TINA.org Inquiry
New ads came and went amid increased attention on U.S. auto manufacturing industry.
Stellantis to Revise Ads Saying Its Cars Are Built in America
Patrick Coffee, The Wall Street Journal
Tariffs Create Opening for ‘Made in America’ Ads—With Carefully Chosen Words
Patrick Coffee, The Wall Street Journal